These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24169799)

  • 1. Mode of action and structure-activity relationship studies of geobacillin I.
    Garg N; Oman TJ; Andrew Wang TS; De Gonzalo CV; Walker S; van der Donk WA
    J Antibiot (Tokyo); 2014 Jan; 67(1):133-6. PubMed ID: 24169799
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriocins: safe, natural antimicrobials for food preservation.
    Cleveland J; Montville TJ; Nes IF; Chikindas ML
    Int J Food Microbiol; 2001 Dec; 71(1):1-20. PubMed ID: 11764886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm.
    Okuda K; Zendo T; Sugimoto S; Iwase T; Tajima A; Yamada S; Sonomoto K; Mizunoe Y
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5572-9. PubMed ID: 23979748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bypassing lantibiotic resistance by an effective nisin derivative.
    Zaschke-Kriesche J; Behrmann LV; Reiners J; Lagedroste M; Gröner Y; Kalscheuer R; Smits SHJ
    Bioorg Med Chem; 2019 Aug; 27(15):3454-3462. PubMed ID: 31253534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineering of the model lantibiotic nisin.
    Field D; Cotter PD; Ross RP; Hill C
    Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens.
    Mota-Meira M; LaPointe G; Lacroix C; Lavoie MC
    Antimicrob Agents Chemother; 2000 Jan; 44(1):24-9. PubMed ID: 10602718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors.
    Yoneyama F; Imura Y; Ichimasa S; Fujita K; Zendo T; Nakayama J; Matsuzaki K; Sonomoto K
    Appl Environ Microbiol; 2009 Jan; 75(2):538-41. PubMed ID: 19011053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-engineering the Antimicrobial Spectrum of Lantibiotics: Activity of Nisin against Gram Negative Bacteria.
    Vukomanović M; Žunič V; Kunej Š; Jančar B; Jeverica S; Podlipec R; Suvorov D
    Sci Rep; 2017 Jun; 7(1):4324. PubMed ID: 28659619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nisin Z and lacticin 3147 improve efficacy of antibiotics against clinically significant bacteria.
    Ellis JC; Ross RP; Hill C
    Future Microbiol; 2019 Dec; 14():1573-1587. PubMed ID: 32019322
    [No Abstract]   [Full Text] [Related]  

  • 10. Lantibiotic resistance.
    Draper LA; Cotter PD; Hill C; Ross RP
    Microbiol Mol Biol Rev; 2015 Jun; 79(2):171-91. PubMed ID: 25787977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
    Li Q; Montalban-Lopez M; Kuipers OP
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactococcal bacteriocins: mode of action and immunity.
    Venema K; Venema G; Kok J
    Trends Microbiol; 1995 Aug; 3(8):299-304. PubMed ID: 8528613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin.
    Chan WC; Leyland M; Clark J; Dodd HM; Lian LY; Gasson MJ; Bycroft BW; Roberts GC
    FEBS Lett; 1996 Jul; 390(2):129-32. PubMed ID: 8706842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic action of pediocin and nisin: recent progress and unresolved questions.
    Montville TJ; Chen Y
    Appl Microbiol Biotechnol; 1998 Nov; 50(5):511-9. PubMed ID: 9917136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide Bacteriocins--Structure Activity Relationships.
    Etayash H; Azmi S; Dangeti R; Kaur K
    Curr Top Med Chem; 2015; 16(2):220-41. PubMed ID: 26265354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-specific variation of Lactobacillus plantarum and Lactobacillus pentosus in sensitivity towards various bacteriocins.
    Carl GD; Leisner JJ; Swings J; Vancanneyt M
    Antonie Van Leeuwenhoek; 2004 Apr; 85(3):209-16. PubMed ID: 15028870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis and mode of action of lantibiotics.
    Chatterjee C; Paul M; Xie L; van der Donk WA
    Chem Rev; 2005 Feb; 105(2):633-84. PubMed ID: 15700960
    [No Abstract]   [Full Text] [Related]  

  • 18. Biomedical applications of nisin.
    Shin JM; Gwak JW; Kamarajan P; Fenno JC; Rickard AH; Kapila YL
    J Appl Microbiol; 2016 Jun; 120(6):1449-65. PubMed ID: 26678028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli.
    Naghmouchi K; Belguesmia Y; Baah J; Teather R; Drider D
    Res Microbiol; 2011; 162(2):99-107. PubMed ID: 20868743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
    Chi H; Holo H
    Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.